Cargando…
Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
A cluster of patients poisoned by herbal medicine in the 1990s revealed that aristolochic acid (AA) causes kidney failure and upper tract urothelial carcinoma (UTUC). Recent research demonstrated that this was not an isolated incident; on the contrary, AA exposure is widespread in East Asia. This ed...
Autores principales: | Boot, Arnoud, Jiang, Nanhai, Rozen, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196294/ https://www.ncbi.nlm.nih.gov/pubmed/32373232 http://dx.doi.org/10.7150/thno.46489 |
Ejemplares similares
-
Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023) -
Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016) -
Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020) -
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021) -
Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)